Cargando…
Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells
DNA endonuclease eight-like glycosylase 3 (NEIL3) is one of the DNA glycosylases that removes oxidized DNA base lesions from single-stranded DNA (ssDNA) and non-B DNA structures. Approximately seven percent of human tumors have an altered NEIL3 gene. However, the role of NEIL3 in replication-associa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762564/ https://www.ncbi.nlm.nih.gov/pubmed/29348879 http://dx.doi.org/10.18632/oncotarget.22896 |
_version_ | 1783291711207768064 |
---|---|
author | Klattenhoff, Alex W. Thakur, Megha Chu, Christopher S. Ray, Debolina Habib, Samy L. Kidane, Dawit |
author_facet | Klattenhoff, Alex W. Thakur, Megha Chu, Christopher S. Ray, Debolina Habib, Samy L. Kidane, Dawit |
author_sort | Klattenhoff, Alex W. |
collection | PubMed |
description | DNA endonuclease eight-like glycosylase 3 (NEIL3) is one of the DNA glycosylases that removes oxidized DNA base lesions from single-stranded DNA (ssDNA) and non-B DNA structures. Approximately seven percent of human tumors have an altered NEIL3 gene. However, the role of NEIL3 in replication-associated repair and its impact on modulating treatment response is not known. Here, we report that NEIL3 is localized at the DNA double-strand break (DSB) sites during oxidative DNA damage and replication stress. Loss of NEIL3 significantly increased spontaneous replication-associated DSBs and recruitment of replication protein A (RPA). In contrast, we observed a marked decrease in Rad51 on nascent DNA strands at the replication fork, suggesting that HR-dependent repair is compromised in NEIL3-deficient cells. Interestingly, NEIL3-deficient cells were sensitive to ataxia–telangiectasia and Rad3 related protein (ATR) inhibitor alone or in combination with PARP1 inhibitor. This study elucidates the mechanism by which NEIL3 is critical to overcome oxidative and replication-associated genotoxic stress. Our findings may have important clinical implications to utilize ATR and PARP1 inhibitors to enhance cytotoxicity in tumors that carry altered levels of NEIL3. |
format | Online Article Text |
id | pubmed-5762564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-57625642018-01-18 Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells Klattenhoff, Alex W. Thakur, Megha Chu, Christopher S. Ray, Debolina Habib, Samy L. Kidane, Dawit Oncotarget Research Paper DNA endonuclease eight-like glycosylase 3 (NEIL3) is one of the DNA glycosylases that removes oxidized DNA base lesions from single-stranded DNA (ssDNA) and non-B DNA structures. Approximately seven percent of human tumors have an altered NEIL3 gene. However, the role of NEIL3 in replication-associated repair and its impact on modulating treatment response is not known. Here, we report that NEIL3 is localized at the DNA double-strand break (DSB) sites during oxidative DNA damage and replication stress. Loss of NEIL3 significantly increased spontaneous replication-associated DSBs and recruitment of replication protein A (RPA). In contrast, we observed a marked decrease in Rad51 on nascent DNA strands at the replication fork, suggesting that HR-dependent repair is compromised in NEIL3-deficient cells. Interestingly, NEIL3-deficient cells were sensitive to ataxia–telangiectasia and Rad3 related protein (ATR) inhibitor alone or in combination with PARP1 inhibitor. This study elucidates the mechanism by which NEIL3 is critical to overcome oxidative and replication-associated genotoxic stress. Our findings may have important clinical implications to utilize ATR and PARP1 inhibitors to enhance cytotoxicity in tumors that carry altered levels of NEIL3. Impact Journals LLC 2017-12-04 /pmc/articles/PMC5762564/ /pubmed/29348879 http://dx.doi.org/10.18632/oncotarget.22896 Text en Copyright: © 2017 Klattenhoff et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (http://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Klattenhoff, Alex W. Thakur, Megha Chu, Christopher S. Ray, Debolina Habib, Samy L. Kidane, Dawit Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells |
title | Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells |
title_full | Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells |
title_fullStr | Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells |
title_full_unstemmed | Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells |
title_short | Loss of NEIL3 DNA glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to ATR inhibitor in glioblastoma cells |
title_sort | loss of neil3 dna glycosylase markedly increases replication associated double strand breaks and enhances sensitivity to atr inhibitor in glioblastoma cells |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762564/ https://www.ncbi.nlm.nih.gov/pubmed/29348879 http://dx.doi.org/10.18632/oncotarget.22896 |
work_keys_str_mv | AT klattenhoffalexw lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells AT thakurmegha lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells AT chuchristophers lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells AT raydebolina lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells AT habibsamyl lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells AT kidanedawit lossofneil3dnaglycosylasemarkedlyincreasesreplicationassociateddoublestrandbreaksandenhancessensitivitytoatrinhibitoringlioblastomacells |